Cefalexin Formulation

Hazard statements (CLP)

H334, H335, H361f, H373

Code

Statements

H334

May cause allergy or asthma symptoms or breathing difficulties if inhaled

SECTION 2: Hazards identification

Regulation (EC) No. 1272/2008 Classification of the substance or mixture

Signal word

Danger

Hazard statements

H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled. H335 May cause respiratory irritation. H361f Suspected of damaging fertility. H373 May cause damage to organs through prolonged or repeated exposure.

Prevention

P201 Obtain special instructions before use. P271 Use only outdoors or in a well-ventilated area. P280 Wear protective gloves/ protective clothing/ eye protec- tion/ face protection.

Response

P304 + P340 + P312 IF INHALED: Remove person to fresh air and keep comfortable for breathing. Call a POISON CENTER/ doctor if you feel unwell. P308 + P313 IF exposed or concerned: Get medical advice/ attention. P342 + P311 If experiencing respiratory symptoms: Call a POISON CENTER/ doctor.

Hazardous Ingredients

Cefalexin The following percentage of the mixture consists of ingredient(s) with unknown hazards to the aquatic environment: 21 %

Other hazards

This substance/mixture contains no components considered to be either persistent, bioaccumula- tive and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher

2.1 Classification of the substance or mixture

Classification (REGULATION (EC) No 1272/2008) Respiratory sensitisation, Category 1 H334: May cause allergy or asthma symptoms or breathing difficulties if inhaled. Reproductive toxicity, Category 2 H361f: Suspected of damaging fertility. Specific target organ toxicity - single ex- H335: May cause respiratory irritation. posure, Category 3 Specific target organ toxicity - repeated H373: May cause damage to organs through pro- exposure, Category 2 longed or repeated exposure.